Correlation between Choline Level Measured by Proton MR Spectroscopy and Ki-67 Labeling Index in Gliomas

References

1. ↵
   Heiss WD, Heindel W, Herholz K, et al. Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors. J Nucl Med 1990;31:302-310

   Abstract/FREE Full Text
2. Herholz K, Heindel W, Luyten PR, et al. In vivo imaging of glucose consumption and lactate concentration in human gliomas. Ann Neurol 1992;31:319-327

   CrossRefPubMedWeb of Science
3. Kameyama M, Tsurumi Y, Shirane R, et al. ¹⁸F-fluoro-2′-deoxyuridine and brain tumor: a new approach to nucleic acid metabolism by ARG and PET. J Cereb Blood Flow Metab 1987;7:459-464
4. Kameyama M, Tsurumi Y, Shirane R, et al. Multi-parametric analysis of brain tumor with PET. J Cereb Blood Flow Metab 1987;7:466-470
5. ↵
   Black LK, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 1989;71:342-346

   CrossRefPubMedWeb of Science
6. Kim KT, Black KL, Marciano D, et al. Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 1990;31:965-969

   Abstract/FREE Full Text
7. ↵
   Louis DN, Edgerton S, Thor AD, Hedley-Whyte ET. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: a comparative study. Acta Neuropathol (Berl) 1991;81:675-679

   CrossRefPubMed
8. Onda K, Davis RL, Shibuya M, Wilson CB, Hoshino T. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 1994;74:1921-1926

   CrossRefPubMedWeb of Science
9. Steck K, El-Naggar AK. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms. Cytometry 1994;17:258-265

   CrossRefPubMedWeb of Science
10. ↵
    Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989;9:79-93

    CrossRefPubMedWeb of Science
11. ↵
    Barker PB, Glickson JD, Bryan RN. In vivo magnetic resonance spectroscopy of human brain tumors. Top Magn Reson Imaging 1993;5:32-45

    PubMed
12. ↵
    Bruhn H, Frahm J, Gyngell ML, et al. Noninvasive differentiation of tumors with use of localized ¹H MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 1989;172:541-548

    CrossRefPubMedWeb of Science
13. ↵
    Demaerel P, Johannik K, Van-Hecke P, et al. Localized ¹H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J Comput Assist Tomogr 1991;15:67-76

    CrossRefPubMed
14. Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185:675-686

    CrossRefPubMed
15. Gill SS, Thomas DG, Van Bruggen N, et al. Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J Comput Assist Tomogr 1990;14:497-504

    CrossRefPubMedWeb of Science
16. Henriksen O, Wieslander S, Gjerris F, Jensen KM. In vivo ¹H-spectroscopy of human intracranial tumors at 1.5 tesla: preliminary experience at a clinical installation. Acta Radiol 1991;32:95-99

    PubMed
17. ↵
    Luyten PR, Marien AJ, Heindel W, et al. Metabolic imaging of patients with intracranial tumors: ¹H MR spectroscopic imaging and PET. Radiology 1990;176:791-799

    CrossRefPubMedWeb of Science
18. McBride DQ, Miller BL, Nikas DL, et al. Analysis of brain tumors using ¹H magnetic resonance spectroscopy. Surg Neurol 1995;44:137-144

    CrossRefPubMedWeb of Science
19. Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996;84:449-458

    CrossRefPubMedWeb of Science
20. Ott D, Hennig J, Ernst T. Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 1993;186:745-752

    CrossRefPubMedWeb of Science
21. Segebarth CM, Baleriaux DF, Luyten PR, den Hollander JA. Detection of metabolic heterogeneity of human intracranial tumors in vivo by ¹H NMR spectroscopy imaging. Magn Reson Med 1990;13:62-76

    CrossRefPubMedWeb of Science
22. ↵
    Hagberg G, Burlina AP, Mader I, Roser W, Radue EW, Seelig J. In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification. Magn Reson Med 1995;34:242-252

    CrossRefPubMed
23. Kugel H, Heindel W, Ernestus R-I, Bunke J, du Mensil R, Friedmann G. Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. Radiology 1992;183:701-709

    CrossRefPubMedWeb of Science
24. Sijens PE, van Dijk P, Oudkerk M. Correlation between choline level and Gd-DTPA enhancement in patients with brain metastases of mammary carcinoma. Magn Reson Med 1994;32:549-555

    CrossRefPubMedWeb of Science
25. Tien RD, Lai PH, Smith JS, Lazeyras F. Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. AJR Am J Roentgenol 1996;35:201-209
26. ↵
    Shimizu H, Kumabe T, Tominaga T, et al. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:737-747

    Abstract
27. ↵
    Kleihues P, Burger PC, Scheithauer BW. Histological Typing of Tumours of the Central Nervous System. 2nd ed. Berlin: Springer; 1993;11-30
28. ↵
    Kumabe T, Shimizu H, Sonoda Y, Shirane R. Thallium-201 single-photon emission computed tomographic and proton magnetic resonance spectroscopic characteristics of intracranial ganglioglioma: report of three cases. Neurosurgery 1999;45:183–187
29. ↵
    Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39:741-748

    CrossRefPubMedWeb of Science
30. ↵
    Chang L, McBride D, Miller BL, et al. Localized in vivo ¹H magnetic resonance spectroscopy and in vitro analyses of heterogeneous brain tumors. J Neuroimaging 1995;5:157-163

    PubMed
31. ↵
    Usenius JP, Kauppinen RA, Vainio PA, et al. Quantitative metabolite patterns of human brain tumors: detection by ¹H NMR spectroscopy in vivo and in vitro. J Comput Assist Tomogr 1994;18:705-713

    CrossRefPubMed